Victory Capital Management Inc. Sells 31,883 Shares of DuPont de Nemours, Inc. $DD

Victory Capital Management Inc. trimmed its holdings in DuPont de Nemours, Inc. (NYSE:DDFree Report) by 20.1% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 126,939 shares of the basic materials company’s stock after selling 31,883 shares during the period. Victory Capital Management Inc.’s holdings in DuPont de Nemours were worth $9,889,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors have also recently made changes to their positions in DD. Salomon & Ludwin LLC raised its stake in shares of DuPont de Nemours by 186.5% during the 3rd quarter. Salomon & Ludwin LLC now owns 318 shares of the basic materials company’s stock valued at $25,000 after purchasing an additional 207 shares during the period. Crews Bank & Trust boosted its stake in DuPont de Nemours by 55.8% in the 3rd quarter. Crews Bank & Trust now owns 508 shares of the basic materials company’s stock worth $40,000 after purchasing an additional 182 shares during the period. Cary Street Partners Investment Advisory LLC grew its holdings in DuPont de Nemours by 67.5% during the 2nd quarter. Cary Street Partners Investment Advisory LLC now owns 541 shares of the basic materials company’s stock valued at $37,000 after buying an additional 218 shares in the last quarter. Aster Capital Management DIFC Ltd bought a new stake in shares of DuPont de Nemours during the third quarter valued at about $44,000. Finally, Pacifica Partners Inc. increased its position in shares of DuPont de Nemours by 27.0% during the third quarter. Pacifica Partners Inc. now owns 602 shares of the basic materials company’s stock valued at $47,000 after buying an additional 128 shares during the period. Hedge funds and other institutional investors own 73.96% of the company’s stock.

DuPont de Nemours Stock Performance

NYSE DD opened at $45.98 on Thursday. DuPont de Nemours, Inc. has a 52-week low of $22.50 and a 52-week high of $52.66. The company has a fifty day moving average of $46.18 and a 200-day moving average of $39.58. The company has a market capitalization of $18.80 billion, a P/E ratio of -24.72, a P/E/G ratio of 1.15 and a beta of 1.10. The company has a debt-to-equity ratio of 0.22, a quick ratio of 1.91 and a current ratio of 2.42.

DuPont de Nemours (NYSE:DDGet Free Report) last released its earnings results on Tuesday, February 10th. The basic materials company reported $0.46 EPS for the quarter, beating analysts’ consensus estimates of $0.43 by $0.03. DuPont de Nemours had a positive return on equity of 7.37% and a negative net margin of 7.03%.The business had revenue of $1.69 billion for the quarter, compared to analysts’ expectations of $1.69 billion. During the same quarter in the prior year, the firm earned $1.13 earnings per share. The firm’s revenue was up .2% on a year-over-year basis. DuPont de Nemours has set its FY 2026 guidance at 2.250-2.300 EPS and its Q1 2026 guidance at 0.480-0.480 EPS. As a group, equities research analysts predict that DuPont de Nemours, Inc. will post 4.38 EPS for the current fiscal year.

DuPont de Nemours Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Monday, March 16th. Investors of record on Monday, March 2nd will be given a $0.20 dividend. This represents a $0.80 dividend on an annualized basis and a yield of 1.7%. The ex-dividend date is Monday, March 2nd. DuPont de Nemours’s dividend payout ratio (DPR) is presently -43.01%.

Analyst Upgrades and Downgrades

DD has been the subject of a number of analyst reports. Jefferies Financial Group raised their price objective on shares of DuPont de Nemours from $51.00 to $59.00 and gave the company a “buy” rating in a research report on Wednesday, February 11th. Wolfe Research raised their price target on shares of DuPont de Nemours from $49.00 to $54.00 and gave the company an “outperform” rating in a report on Wednesday, February 11th. Royal Bank Of Canada upped their price target on shares of DuPont de Nemours from $51.00 to $60.00 and gave the stock an “outperform” rating in a report on Tuesday, February 17th. Citigroup lifted their price objective on DuPont de Nemours from $50.00 to $59.00 and gave the company a “buy” rating in a research note on Wednesday, February 11th. Finally, UBS Group upped their target price on DuPont de Nemours from $49.00 to $56.00 and gave the stock a “buy” rating in a research note on Wednesday, February 11th. One analyst has rated the stock with a Strong Buy rating, twelve have given a Buy rating, three have issued a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $51.86.

Read Our Latest Stock Analysis on DD

About DuPont de Nemours

(Free Report)

DuPont de Nemours (NYSE: DD) is a global science and engineering company that develops and supplies specialty materials, chemicals and industrial biosciences for a wide range of markets. Headquartered in Wilmington, Delaware, the company traces its origins to 1802 and has evolved through more than two centuries of innovation. In recent history DuPont participated in a major combination with Dow Chemical and subsequent reorganization that refocused the company on differentiated, specialty businesses built around science-based solutions.

DuPont’s operations center on advanced materials and technologies used by manufacturers and OEMs in industries such as transportation, electronics, construction, industrial manufacturing and worker safety.

See Also

Want to see what other hedge funds are holding DD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DuPont de Nemours, Inc. (NYSE:DDFree Report).

Institutional Ownership by Quarter for DuPont de Nemours (NYSE:DD)

Receive News & Ratings for DuPont de Nemours Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DuPont de Nemours and related companies with MarketBeat.com's FREE daily email newsletter.